| 25 May 2026 |
ARA-290 |
8.6 |
5mg |
5.3mg |
+6.0% |
97.95% |
Lab G |
| 25 May 2026 |
S-23 Raw |
6.9 |
5g |
5.9g |
+18.9% |
98.89% |
Lab A |
| 24 May 2026 |
Boldenone Cypionate |
6.2 |
200mg/ml |
209.1mg/ml |
+4.6% |
96.80% |
Lab A |
| 24 May 2026 |
Cerebrolysin |
5.9 |
2mg |
2.1mg |
+7.5% |
99.60% |
Lab D |
| 24 May 2026 |
IGF-1 LR3 |
6.3 |
5mg |
5.9mg |
+17.5% |
96.61% |
Lab D |
| 24 May 2026 |
Livagen |
9.1 |
15mg |
15.6mg |
+4.2% |
99.92% |
Lab E |
| 24 May 2026 |
Nandrolone Phenylpropionate (NPP) Raw |
7.3 |
5g |
4.9g |
-2.5% |
95.45% |
Lab E |
| 24 May 2026 |
Ovagen |
8.8 |
20mg |
21.3mg |
+6.5% |
95.31% |
Lab F |
| 24 May 2026 |
Retatrutide 30mg Pen Kit |
8.0 |
20mg |
18.0mg |
-10.2% |
96.56% |
Lab E |
| 24 May 2026 |
Tren Hex |
6.9 |
200mg/ml |
185.5mg/ml |
-7.3% |
99.30% |
Lab G |
| 24 May 2026 |
YK11 |
7.7 |
20mg |
22.6mg |
+12.8% |
97.87% |
Lab G |
| 24 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
7.2 |
30mg |
33.0mg |
+9.9% |
99.48% |
Lab G |
| 24 May 2026 |
EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 |
6.9 |
100g |
123.5g |
+23.5% |
99.65% |
Lab F |
| 24 May 2026 |
Retatrutide 30mg Pen Kit |
9.1 |
15mg |
17.2mg |
+14.4% |
96.27% |
Lab B |
| 24 May 2026 |
Andarine S4 |
6.6 |
25mg |
23.4mg |
-6.3% |
96.53% |
Lab C |
| 24 May 2026 |
Boldenone Cypionate |
5.3 |
250mg/ml |
281.6mg/ml |
+12.6% |
96.21% |
Lab F |
| 24 May 2026 |
Nandrolone Phenylpropionate (NPP) Raw |
8.1 |
5g |
4.4g |
-12.6% |
97.24% |
Lab G |
| 24 May 2026 |
Ovagen |
7.2 |
10mg |
12.0mg |
+19.7% |
98.94% |
Lab C |
| 24 May 2026 |
Oxymetholone (Anadrol) Raw |
6.9 |
500g |
431.5g |
-13.7% |
97.81% |
Lab C |
| 24 May 2026 |
Abaloparatide |
6.8 |
15mg |
18.5mg |
+23.2% |
95.73% |
Lab E |
| 24 May 2026 |
Cerebrolysin |
6.3 |
50mg |
54.2mg |
+8.3% |
95.62% |
Lab B |
| 24 May 2026 |
Liraglutide |
8.9 |
50mg |
53.7mg |
+7.4% |
98.44% |
Lab B |
| 24 May 2026 |
MOTS-C |
6.6 |
2mg |
1.8mg |
-9.3% |
98.81% |
Lab A |
| 24 May 2026 |
MOTS-C |
9.2 |
2mg |
2.2mg |
+7.8% |
96.24% |
Lab E |
| 24 May 2026 |
Test Base (No Ester) |
8.4 |
100mg/ml |
111.7mg/ml |
+11.7% |
95.18% |
Lab F |
| 24 May 2026 |
TrenMix 200 |
6.4 |
100mg/ml |
113.2mg/ml |
+13.2% |
97.33% |
Lab C |
| 24 May 2026 |
Cerebrolysin |
6.6 |
20mg |
20.9mg |
+4.7% |
97.34% |
Lab E |
| 24 May 2026 |
CJC-1295 With DAC |
7.0 |
10mg |
10.2mg |
+1.5% |
96.89% |
Lab E |
| 24 May 2026 |
GHRP-2 Acetate |
5.6 |
20mg |
23.7mg |
+18.7% |
95.37% |
Lab B |
| 24 May 2026 |
Liraglutide |
8.3 |
10mg |
9.2mg |
-7.9% |
99.25% |
Lab C |
| 24 May 2026 |
Trestolone Enanthate Raw |
9.3 |
500g |
471.5g |
-5.7% |
98.45% |
Lab B |
| 23 May 2026 |
MOTS-C |
7.8 |
20mg |
24.6mg |
+22.9% |
95.11% |
Lab G |
| 23 May 2026 |
Oxymetholone (Anadrol) Raw |
7.6 |
10g |
10.3g |
+2.5% |
96.11% |
Lab F |
| 23 May 2026 |
S-23 Raw |
7.0 |
1g |
1.1g |
+9.0% |
95.79% |
Lab G |
| 23 May 2026 |
S-23 Raw |
7.8 |
5g |
5.2g |
+3.6% |
95.00% |
Lab F |
| 23 May 2026 |
Trestolone Enanthate Raw |
8.3 |
5g |
6.1g |
+21.5% |
95.48% |
Lab D |
| 23 May 2026 |
CJC-1295 With DAC |
6.8 |
2mg |
2.0mg |
-0.9% |
99.87% |
Lab E |
| 23 May 2026 |
Selank |
5.9 |
20mg |
24.6mg |
+23.2% |
99.17% |
Lab B |
| 23 May 2026 |
TrenMix 200 |
7.0 |
250mg/ml |
306.8mg/ml |
+22.7% |
99.40% |
Lab G |
| 22 May 2026 |
BPC-157 |
7.7 |
5mg |
6.0mgpackage |
5.33mg |
-11.0% |
BPC25-05-002 |
| 21 May 2026 |
ACE-031 |
6.9 |
10mg |
12.3mg |
+23.3% |
98.85% |
Lab G |
| 21 May 2026 |
Arimidex (Anastrozole) |
8.1 |
20mg |
18.4mg |
-8.0% |
97.77% |
Lab B |
| 21 May 2026 |
KissPeptin-10 |
5.8 |
20mg |
18.8mg |
-6.1% |
98.79% |
Lab G |
| 21 May 2026 |
Oxymetholone (Anadrol) Raw |
7.6 |
500g |
497.2g |
-0.6% |
97.84% |
Lab E |
| 21 May 2026 |
Tren Hex |
7.6 |
100mg/ml |
123.2mg/ml |
+23.2% |
96.78% |
Lab F |
| 21 May 2026 |
TrenMix 200 |
9.9 |
250mg/ml |
238.9mg/ml |
-4.4% |
97.70% |
Lab G |
| 21 May 2026 |
Trestolone Enanthate Raw |
6.8 |
500g |
562.5g |
+12.5% |
96.54% |
Lab A |
| 21 May 2026 |
Tirzepatide |
8.0 |
30mg |
(no batch claim) |
30.7mg |
+2.3% |
(no batch ID) |
| 21 May 2026 |
Liraglutide |
8.3 |
5mg |
6.1mg |
+21.5% |
96.47% |
Lab C |
| 21 May 2026 |
Methylamine (base) CAS 74-89-5 |
7.4 |
1g |
1.0g |
+3.4% |
96.91% |
Lab E |
| 21 May 2026 |
Ovagen |
6.8 |
2mg |
1.7mg |
-13.7% |
95.26% |
Lab G |
| 21 May 2026 |
PE 22-28 |
5.3 |
2mg |
2.2mg |
+7.8% |
98.04% |
Lab A |
| 21 May 2026 |
TrenMix 200 |
8.7 |
250mg/ml |
271.0mg/ml |
+8.4% |
97.52% |
Lab G |
| 20 May 2026 |
ARA-290 |
6.7 |
50mg |
52.3mg |
+4.6% |
99.85% |
Lab A |
| 20 May 2026 |
Arimidex (Anastrozole) |
7.1 |
50mg |
56.9mg |
+13.9% |
98.60% |
Lab C |
| 20 May 2026 |
Boldenone Cypionate |
9.5 |
250mg/ml |
256.6mg/ml |
+2.6% |
98.86% |
Lab E |
| 20 May 2026 |
BPC157 10mg + TB500 10mg Blend |
4.3 |
20mg |
20.4mg |
+2.0% |
95.55% |
Lab G |
| 20 May 2026 |
IGF-1 LR3 |
6.3 |
20mg |
19.4mg |
-3.0% |
96.28% |
Lab C |
| 20 May 2026 |
Liraglutide |
10.0 |
30mg |
35.0mg |
+16.7% |
96.88% |
Lab F |
| 20 May 2026 |
Ovagen |
7.8 |
5mg |
5.8mg |
+15.1% |
97.10% |
Lab E |
| 20 May 2026 |
Primobolan Oral (Methenolone Acetate) |
6.7 |
50mg |
56.3mg |
+12.6% |
96.93% |
Lab F |
| 19 May 2026 |
Abaloparatide |
8.3 |
30mg |
33.4mg |
+11.4% |
97.35% |
Lab F |
| 19 May 2026 |
ACE-031 |
7.2 |
20mg |
23.1mg |
+15.3% |
98.46% |
Lab A |
| 19 May 2026 |
CJC-1295 With DAC |
6.2 |
15mg |
13.7mg |
-8.7% |
96.63% |
Lab A |
| 19 May 2026 |
FOXO4 |
7.9 |
15mg |
13.8mg |
-8.2% |
96.81% |
Lab C |
| 19 May 2026 |
PE 22-28 |
7.5 |
15mg |
16.9mg |
+12.9% |
98.61% |
Lab A |
| 19 May 2026 |
Selank |
8.1 |
5mg |
5.6mg |
+12.4% |
99.23% |
Lab F |
| 19 May 2026 |
Tren Hex |
5.5 |
250mg/ml |
272.4mg/ml |
+9.0% |
95.41% |
Lab E |
| 17 May 2026 |
Tesamorelin |
5.0 |
10mg |
(no batch claim) |
11.6mg |
+16.0% |
(no batch ID) |
| 17 May 2026 |
Ipamorelin |
7.7 |
10mg |
11.6mgpackage |
10.4mg |
-10.2% |
IPA-10-001 |
| 17 May 2026 |
ARA-290 |
7.4 |
30mg |
29.3mg |
-2.5% |
98.58% |
Lab F |
| 17 May 2026 |
Boldenone Cypionate |
5.8 |
250mg/ml |
229.5mg/ml |
-8.2% |
95.64% |
Lab F |
| 17 May 2026 |
DHB (1-Test Cyp) Oral |
5.1 |
20mg |
23.1mg |
+15.5% |
95.82% |
Lab F |
| 17 May 2026 |
DHB (1-Test Cyp) Oral |
7.2 |
10mg |
11.8mg |
+17.8% |
98.09% |
Lab D |
| 17 May 2026 |
FOXO4 |
10.0 |
20mg |
17.4mg |
-13.2% |
97.37% |
Lab G |
| 17 May 2026 |
S-23 Raw |
6.2 |
5g |
4.3g |
-13.3% |
96.03% |
Lab A |
| 17 May 2026 |
YK11 |
4.8 |
25mg |
29.8mg |
+19.1% |
99.42% |
Lab B |
| 29 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
7.3 |
20mg |
21.1mg |
+5.6% |
99.86% |
Lab D |
| 29 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
7.6 |
2mg |
2.2mg |
+8.4% |
97.21% |
Lab D |
| 29 Jan 2026 |
IGF-1 LR3 |
7.4 |
20mg |
21.2mg |
+6.0% |
98.66% |
Lab A |
| 29 Jan 2026 |
Livagen |
6.1 |
20mg |
20.9mg |
+4.5% |
97.67% |
Lab G |
| 29 Jan 2026 |
PE 22-28 |
8.0 |
2mg |
2.1mg |
+4.4% |
96.31% |
Lab D |
| 26 Jan 2026 |
Tirzepatide |
7.2 |
60mg |
(no batch claim) |
64.5mg |
+7.5% |
(no batch ID) |
| 26 Jan 2026 |
Abaloparatide |
6.5 |
15mg |
13.7mg |
-8.7% |
95.45% |
Lab F |
| 26 Jan 2026 |
Boldenone Cypionate |
6.1 |
250mg/ml |
288.9mg/ml |
+15.5% |
95.37% |
Lab E |
| 26 Jan 2026 |
TrenMix 200 |
7.6 |
200mg/ml |
219.0mg/ml |
+9.5% |
98.94% |
Lab C |
| 19 Jan 2026 |
DHB (1-Test Cyp) Oral |
8.6 |
100mg |
103.8mg |
+3.8% |
98.45% |
Lab A |
| 19 Jan 2026 |
Tren Hex |
7.7 |
100mg/ml |
97.8mg/ml |
-2.2% |
97.09% |
Lab D |
| 9 Jan 2026 |
Tesamorelin |
5.6 |
10mg |
10.7mglabel |
9.38mg |
-12.1% |
TESA25-10-004 |
| 9 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
4.1 |
15mg |
13.5mg |
-9.8% |
96.83% |
Lab F |
| 9 Jan 2026 |
Primobolan Oral (Methenolone Acetate) |
9.6 |
50mg |
57.0mg |
+14.1% |
97.24% |
Lab D |
| 9 Jan 2026 |
Tren Hex |
6.5 |
250mg/ml |
270.7mg/ml |
+8.3% |
95.25% |
Lab B |
| 9 Jan 2026 |
YK11 |
7.9 |
10mg |
9.8mg |
-1.6% |
98.76% |
Lab C |
| 7 Jan 2026 |
BPC157 10mg + TB500 10mg Blend |
4.8 |
15mg |
16.2mg |
+8.1% |
99.73% |
Lab G |
| 7 Jan 2026 |
KissPeptin-10 |
6.7 |
5mg |
5.6mg |
+12.0% |
96.58% |
Lab C |
| 7 Jan 2026 |
KissPeptin-10 |
6.0 |
5mg |
5.9mg |
+18.7% |
97.89% |
Lab D |
| 7 Jan 2026 |
S-23 Raw |
10.0 |
100g |
122.5g |
+22.5% |
97.04% |
Lab A |
| 6 Jan 2026 |
Abaloparatide |
6.5 |
50mg |
50.9mg |
+1.8% |
96.69% |
Lab E |
| 6 Jan 2026 |
IGF-1 LR3 |
7.6 |
10mg |
11.4mg |
+13.6% |
95.44% |
Lab D |
| 29 Dec 2025 |
Cerebrolysin |
6.2 |
5mg |
6.0mg |
+19.1% |
95.49% |
Lab F |
| 29 Dec 2025 |
FOXO4 |
7.5 |
30mg |
32.1mg |
+7.0% |
99.94% |
Lab F |
| 29 Dec 2025 |
FOXO4 |
9.6 |
50mg |
44.0mg |
-11.9% |
97.45% |
Lab F |
| 29 Dec 2025 |
Methylamine (base) CAS 74-89-5 |
6.1 |
10g |
10.6g |
+5.8% |
95.57% |
Lab C |
| 29 Dec 2025 |
Oxymetholone (Anadrol) Raw |
7.0 |
1g |
1.1g |
+7.7% |
97.18% |
Lab A |
| 16 Dec 2025 |
BPC-157 |
6.9 |
10mg |
11.4mglabel |
10.6mg |
-6.7% |
BPC25-10-001 |
| 12 Dec 2025 |
Abaloparatide |
5.4 |
50mg |
60.5mg |
+20.9% |
96.31% |
Lab G |
| 12 Dec 2025 |
BPC157 10mg + TB500 10mg Blend |
5.2 |
15mg |
14.0mg |
-6.5% |
95.77% |
Lab G |
| 12 Dec 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
8.4 |
50mg |
43.9mg |
-12.2% |
97.22% |
Lab G |
| 12 Dec 2025 |
DHB (1-Test Cyp) Oral |
5.6 |
20mg |
23.8mg |
+19.2% |
95.76% |
Lab C |
| 5 Dec 2025 |
Primobolan Oral (Methenolone Acetate) |
8.1 |
20mg |
21.2mg |
+5.9% |
99.66% |
Lab C |
| 5 Dec 2025 |
Test Base (No Ester) |
9.3 |
250mg/ml |
239.9mg/ml |
-4.0% |
99.81% |
Lab A |
| 5 Dec 2025 |
Tren Hex |
8.3 |
100mg/ml |
106.4mg/ml |
+6.4% |
96.44% |
Lab D |
| 5 Dec 2025 |
Trestolone Enanthate Raw |
9.3 |
10g |
10.3g |
+3.2% |
98.97% |
Lab B |
| 23 Nov 2025 |
BPC157 10mg + TB500 10mg Blend |
7.0 |
20mg |
23.0mg |
+14.8% |
96.94% |
Lab C |
| 23 Nov 2025 |
CJC-1295 With DAC |
8.6 |
10mg |
9.2mg |
-7.9% |
99.86% |
Lab A |
| 23 Nov 2025 |
IGF-1 LR3 |
9.6 |
15mg |
14.1mg |
-5.9% |
95.10% |
Lab F |
| 23 Nov 2025 |
Test Base (No Ester) |
10.0 |
200mg/ml |
213.6mg/ml |
+6.8% |
98.70% |
Lab B |
| 23 Nov 2025 |
Trestolone Enanthate Raw |
8.3 |
5g |
5.8g |
+15.5% |
96.71% |
Lab B |
| 17 Nov 2025 |
FOXO4 |
8.9 |
10mg |
12.5mg |
+24.7% |
99.32% |
Lab A |
| 17 Nov 2025 |
KissPeptin-10 |
5.4 |
5mg |
5.9mg |
+17.9% |
97.26% |
Lab E |
| 17 Nov 2025 |
Oxymetholone (Anadrol) Raw |
8.0 |
5g |
4.5g |
-9.8% |
96.73% |
Lab D |
| 14 Nov 2025 |
ARA-290 |
9.0 |
5mg |
4.3mg |
-13.2% |
95.50% |
Lab B |
| 14 Nov 2025 |
Boldenone Cypionate |
6.7 |
250mg/ml |
235.7mg/ml |
-5.7% |
95.57% |
Lab F |
| 14 Nov 2025 |
BPC157 10mg + TB500 10mg Blend |
7.9 |
20mg |
23.0mg |
+14.9% |
98.04% |
Lab F |
| 5 Nov 2025 |
Abaloparatide |
8.9 |
30mg |
36.6mg |
+22.0% |
99.20% |
Lab C |
| 5 Nov 2025 |
CJC-1295 With DAC |
6.6 |
15mg |
17.9mg |
+19.1% |
96.17% |
Lab B |
| 5 Nov 2025 |
DHB (1-Test Cyp) Oral |
7.7 |
100mg |
124.7mg |
+24.7% |
98.46% |
Lab D |
| 5 Nov 2025 |
Livagen |
5.5 |
15mg |
15.7mg |
+5.0% |
95.48% |
Lab G |
| 5 Nov 2025 |
Livagen |
8.0 |
5mg |
5.4mg |
+8.1% |
98.90% |
Lab B |
| 5 Nov 2025 |
PE 22-28 |
5.2 |
30mg |
26.7mg |
-11.1% |
97.44% |
Lab C |
| 5 Nov 2025 |
Selank |
6.8 |
10mg |
10.2mg |
+1.8% |
99.22% |
Lab G |
| 5 Nov 2025 |
Tren Hex |
7.9 |
300mg/ml |
290.9mg/ml |
-3.0% |
95.18% |
Lab F |
| 5 Nov 2025 |
Trestolone Enanthate Raw |
6.7 |
5g |
5.6g |
+12.7% |
99.25% |
Lab G |
| 4 Nov 2025 |
Cerebrolysin |
5.7 |
20mg |
20.0mg |
-0.2% |
99.15% |
Lab A |
| 4 Nov 2025 |
CJC-1295 With DAC |
7.9 |
10mg |
9.1mg |
-9.1% |
96.43% |
Lab A |
| 4 Nov 2025 |
FOXO4 |
5.7 |
5mg |
6.0mg |
+20.8% |
99.81% |
Lab B |
| 4 Nov 2025 |
Livagen |
7.0 |
10mg |
10.5mg |
+4.5% |
96.65% |
Lab F |
| 4 Nov 2025 |
Nandrolone Phenylpropionate (NPP) Raw |
8.9 |
100g |
109.9g |
+9.9% |
99.76% |
Lab F |
| 4 Nov 2025 |
Ovagen |
7.5 |
15mg |
13.1mg |
-12.6% |
97.55% |
Lab B |
| 4 Nov 2025 |
Oxymetholone (Anadrol) Raw |
8.3 |
10g |
8.8g |
-12.4% |
95.53% |
Lab G |
| 4 Nov 2025 |
Primobolan Oral (Methenolone Acetate) |
9.9 |
100mg |
93.2mg |
-6.8% |
96.34% |
Lab F |
| 4 Nov 2025 |
Selank |
7.3 |
15mg |
14.1mg |
-6.3% |
95.96% |
Lab G |
| 4 Nov 2025 |
TrenMix 200 |
6.8 |
300mg/ml |
268.3mg/ml |
-10.6% |
98.51% |
Lab D |
| 17 Oct 2025 |
ARA-290 |
6.8 |
20mg |
17.9mg |
-10.5% |
99.29% |
Lab F |
| 17 Oct 2025 |
Cerebrolysin |
6.6 |
50mg |
49.5mg |
-1.1% |
99.16% |
Lab G |
| 17 Oct 2025 |
IGF-1 LR3 |
8.8 |
5mg |
5.8mg |
+16.6% |
99.70% |
Lab E |
| 17 Oct 2025 |
KissPeptin-10 |
7.1 |
2mg |
2.4mg |
+21.2% |
98.57% |
Lab C |
| 17 Oct 2025 |
Ovagen |
8.8 |
30mg |
33.0mg |
+10.1% |
96.34% |
Lab B |
| 17 Oct 2025 |
Selank |
7.4 |
30mg |
34.1mg |
+13.8% |
98.96% |
Lab B |
| 17 Oct 2025 |
Trestolone Enanthate Raw |
8.2 |
1g |
1.2g |
+16.7% |
97.92% |
Lab E |
| 17 Oct 2025 |
YK11 |
5.3 |
20mg |
22.3mg |
+11.7% |
98.83% |
Lab A |
| 9 Oct 2025 |
ARA-290 |
7.9 |
5mg |
5.0mg |
+0.5% |
98.41% |
Lab C |
| 9 Oct 2025 |
Cerebrolysin |
5.8 |
15mg |
14.1mg |
-6.1% |
97.96% |
Lab G |
| 9 Oct 2025 |
CJC-1295 With DAC |
8.3 |
10mg |
10.7mg |
+7.4% |
98.68% |
Lab C |
| 9 Oct 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
8.2 |
20mg |
23.9mg |
+19.7% |
98.16% |
Lab B |
| 9 Oct 2025 |
PE 22-28 |
8.2 |
10mg |
11.4mg |
+14.3% |
96.93% |
Lab F |
| 9 Oct 2025 |
T3 (Liothyronine) |
9.0 |
25mg |
23.7mg |
-5.3% |
96.96% |
Lab D |
| 3 Oct 2025 |
Abaloparatide |
7.7 |
50mg |
61.9mg |
+23.9% |
96.40% |
Lab B |
| 3 Oct 2025 |
Andarine S4 |
7.3 |
50mg |
46.1mg |
-7.8% |
95.34% |
Lab G |
| 3 Oct 2025 |
DHB (1-Test Cyp) Oral |
6.2 |
10mg |
12.2mg |
+22.1% |
97.58% |
Lab G |
| 3 Oct 2025 |
KissPeptin-10 |
7.5 |
15mg |
14.8mg |
-1.4% |
99.25% |
Lab B |